News List
Holiday Notice of Dragon Boat Festival
2019-06-01
To all departments and employees:According to the related national legal & the actual situation of our company, we i
Long-term anti-AIDS, Combination of two schemes submits application
2019-05-29
On April 29, 2019，the anti-AIDS long-acting two-party “cabotegravir + Ripirilin”submitted to the FDA for listing applica
For the initial treatment of HIV patients, the FDA approved the first dual-agent combination therapy
2019-04-27
Today, the US FDA announced that it has approved the listing of the antiviral therapy Dovato (dolutegravir and lamivudin
Novartis‘s Multiple sclerosis Innovative drug approved
2019-03-29
Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for the treatment of recur
Highly efficient trifluoromethylation and [18F]trifluoromethylation
2019-03-02
Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, has created a new trif
Redox neutral [4+1] cyclic reaction based on C-F fracture
2019-01-19
Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Technology and Professor R
FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors
2018-12-15
Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a co-developed VITRAKVI
FDA approves new mechanism for listing new anti-influenza drugs
2018-11-17
Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil), jointly developed
FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer
2018-10-20
Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate of 5%. In the United
For the first time, scientists have discovered fluorine in natural conditions
2018-09-20
Fluorine is the most reactive chemical element. That is why it is not found in nature in its elemental form, but only in